As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
We received an updated WNV package insert; please note the manufacturer and license number has been ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...